Neuralink Surgery Postponed for Brain-Implant Startup’s Second Patient
The procedure to implant company’s technology was halted due to the patient’s medical condition
Elon Musk’s Neuralink is working to restore function to paralyzed patients.
Photographer: Gabby Jones/BloombergThis article is for subscribers only.
Neuralink Corp., the brain-implant company founded by Elon Musk, was set to implant its device in a second patient last Monday, but the surgery was halted due to the patient’s medical condition, said Michael Lawton, chief executive officer of the Barrow Neurological Institute.
The patient had health issues that made the person an unsuitable candidate for current participation in Neuralink’s study of its experimental device, Lawton said during a phone call. A replacement candidate will likely undergo the surgery next month at the Barrow facility.